Post‐BTK inhibitor mantle cell lymphoma: When is CAR‐T not the answer?

Autor: Rory McCulloch

Publikováno v: British Journal of Haematology.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae46ecd68ca9c4a711a28201025a37d2
https://doi.org/10.1111/bjh.18868

Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019

Autor: Tom P. Bull, Rory McCulloch, Phillip L.R. Nicolson, Andrew J. Doyle, Rebecca J. Shaw, Alexander Langridge, Zara Sayar, David L. Tucker, Michala Pettit, Rita Perry, William Thomas, Catherine Page, Ioana Whalley, Tina Dutt, Louise Garth, Will Lester, Richard J. Buka, Mary Subhan, Victoria Ware, Rachel Rayment, Daniel Castle, Astrid Etherington, Luke Carter‐Brzezinski, Jayne Peters, Claire Corrigan, Narind Sharma, Gary Benson, Sarah Challenor, Thomas S. Skinner, Rui Zhao, Lyndsay A.G. McLeod‐Kennedy, Kenneth Douglas, Amy Knott, Sophie Smith, Julia Wolf, Sophie A. Todd, Vickie McDonald, Alexandros Rampotas, Christopher Dean, Gavinda Sangha, Sue Pavord, Nicholas Denny, Sarah Jaafar, David P.T. McLaughlin, Jennifer E. Ross, Mamatha Karanth, Sarah L. Beverstock, Lynn Mansonso, Samuel H. Burrows, Sudhir Tauro, Amir Shenouda, Benjamin M. Bailiff, Daniel Kajita, Joannes Hermans, Harshita Goradia, Emily M. Finan, Sarah Alford, Keir Pickard, Brigit Greystoke, Thomas Fail, Asmaa Abdussalam, Lara N Roberts, James B. Clark, Natalie Heeney, Jennifer Young, Jamie Maddox, Swathy Srinath, Jahanzeb Khawaja, Jayne Parkes, Samah Babiker, Beverley J. Hunt, Sarah L. Wheeldon, Paul Kerr, Molham Tahhan, Mark Vickers, Alexandra C. Pike, Quentin Hill, Nadreen Mustafa, Azza Almaremi, Emily Hughes, Sean J.F. McGoldrick, Eleana Loizou, Izabela James, Sara R. Boyce, Isabel Farmer, Murugaiyan Thanigaikumar, Katherine Wickenden, Richard Gooding, Kathryn Thornton, Clare Kane, Adam Cole, JessicaC Griffin, Suzanne Docherty, Kiri I. Dixon, Josephine Crowe, Mathew Sheridan, Corinne De Lord, Amit Sud, Anna Austin, Nichola Coooper, Chris Bailey, Luke Attwell, Rachel Hall, Benjamin Gray, Salena R. Chauhan, Anand Lokare, Amy Gudger, Claire Horgan, Indrani Venkatadasari, Israa Kaddam, Claire L. Mapplebeck, Joost Van Veen, Maya Raj, Kanchana De Abrew, Edward Belsham, Cecilia Gyansah, Shalal Sadullah, Beena Salhan, Richard Murrin, Rhys L. Williams, Andrew Stewart, Naomi Cornish, Sophie Otton, Zeeshan Khan, Sam Ackroyd, Lucia Y. Chen, Nicholas P. Lafferty, Francesca Leonforte, Nicholas Pemberton, Emanal Rawi, Diana Triantafyllopoulou, Jagdish Adiyodi, Jun Yong, Elizabeth Jones, David Davies, Rachel C. Peck, Robson Philip, Thomas Seddon, Paul Cahalin, Catherine Prodger, David A. Dutton, Alexander J. Sternberg, Rajani Chengal, Paolo Polzella, Marie Scully

Publikováno v: Journal of Thrombosis and Haemostasis. 20:1428-1436

Acute thrombotic thrombocytopenic purpura (TTP) is a life-threatening emergency and plasma exchange (PEX) is the initial treatment shown to reduce acute mortality.To compare current practice in the United Kingdom (UK) against the standards set out in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95281090a0a343a334aaf4b2a909e51f
https://doi.org/10.1111/jth.15681

Primary central nervous system lymphoma: a practical guide for neurologists

Autor: Toni Saad, Alexander Tuck, Farhad Golestani, Paul Smith, Rory McCulloch

Publikováno v: Practical Neurology. :pn-2022

Primary central nervous system lymphoma is rare, comprising 4% of intracranial neoplasms. Although haematologists or oncologists subsequently manage the condition, it is often neurologists who first make, or at least suspect, the diagnosis. This arti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b7b85f09955200f3e5d4db109f83618f
https://doi.org/10.1136/pn-2022-003656

Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patients

Autor: Safia Dawi, Andrew Robinson, Annabel McMillan, David Lewis, Simon Rule, Simon Bolam, Harshita Goradia, Samuel Harrison, Oliver Miles, Jonathan Lambert, Rosalynd Johnston, George A Follows, Matthew R. Wilson, Rory McCulloch, Toby A. Eyre, Wendy Osborne, Neil Phillips, Russell Patmore, David Dutton, Mark Bishton, Pam McKay, Nicola Crosbie, Anita Arasaretnam, Thomas Creasey, Amy A Kirkwood

Funder: Janssen Pharmaceuticals; Id: http://dx.doi.org/10.13039/100008897
Ibrutinib is an established treatment for relapsed/refractory (R/R) mantle cell lymphoma (MCL) and clinical trial data supports use at second line compared to later relaps

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1883ebb41b9604c2115161a2259a9494

Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study

Autor: Guido Gini, Piero Maria Stefani, Luca Nassi, Tommasina Perrone, Simon Rule, Monica Balzarotti, Cristina Tecchio, Valentina Bozzoli, Antonello Sica, Luca Arcaini, Alessandro Re, Carlo Visco, Annalisa Chiappella, Maria Christina Cox, Simone Ferrero, Roberta Sciarra, Maria Chiara Tisi, Mauro Krampera, Chiara Rusconi, Andrea Evangelista, Vittorio Ruggero Zilioli, Maria Isabel Alvarez De Celis, Alice Di Rocco, Elsa Pennese, Ana Marin-Niebla, Rory McCulloch, Alberto Fabbri, Umberto Vitolo, Lucia Morello, Francesca Maria Quaglia, Stefan Hohaus, Valentina Polli, Luca Petrucci

Patients with mantle cell lymphoma (MCL) that fail induction treatment represent a difficult-to-treat population, where no standard therapy exists. We evaluated outcomes in patients with first relapsed-refractory (r/r) MCL after upfront high dose cyt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cb9271c7ec247f0468782f0ca4b6036
http://hdl.handle.net/2318/1791410